Last updated at 15 Jul 2024 04:35 PM
Director
DIN: 08485241
Thampi Parameswaran is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at SRI CHAKRA INSTITUTE OF MEDICAL SCIENCE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08485241.Thampi Parameswaran is currently involved in 2 different roles. Their most recent position is with SRESHTATHA PRIVATE LIMITED as a Director. The first company Thampi Parameswaran was appointed to as a director was SRI CHAKRA INSTITUTE OF MEDICAL SCIENCE PRIVATE LIMITED. Thampi Parameswaran has a status of Deactivated. Please verify the details for any specific requirements or conditions.
Thampi Parameswaran is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at SRI CHAKRA INSTITUTE OF MEDICAL SCIENCE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08485241.Thampi Parameswaran is currently involved in 2 different roles. Their most recent position is with SRESHTATHA PRIVATE LIMITED as a Director. The first company Thampi Parameswaran was appointed to as a director was SRI CHAKRA INSTITUTE OF MEDICAL SCIENCE PRIVATE LIMITED. Thampi Parameswaran has a status of Deactivated. Please verify the details for any specific requirements or conditions.
4
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 4m 8 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SRI CHAKRA INSTITUTE OF MEDICAL SCIENCE PRIVATE LIMITED | Individual Promoter | 17-Jun-2019 |
| SRI CHAKRA INSTITUTE OF MEDICAL SCIENCE PRIVATE LIMITED | Director | 17-Jun-2019 |
| SRESHTATHA PRIVATE LIMITED | Director | 28-Sep-2020 |
| SRESHTATHA PRIVATE LIMITED | Individual Promoter | 28-Sep-2020 |